RA Flashcards

1
Q

What is affected by inflammation in RA and what happens?

A

Inner skin of the joints (synovialis),

Inflammation, pannus formation, soft tissue, cartilage and bone destruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Whats the women/men ration and age of onset in RA?

A

3:1 women/men

age 35-50 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Name the three stages/steps of pathogenesis of RA

A

1) unknown, multifactorial trigger
2) activation of innate immune system
3) formation ob ab against citrullinated proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What happens during 1) unknown trigger in RA?

A

Stress (tobacco smoke, infections, dust, air pollution) on mucosal interfaces
–> barrier dysfunction in mouth lung and intestine
local micromillieu at interfaces: humoral factors (complement, antimicrobial peptides) and cellular factors (APC, neutrophils, TLR-signalling, sec. lymphoid tissues)

–> disturbance of balance = immune reaction and inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How ist the innate immune system 2) induced in RA?

A

e.g. smoke induces activation of macrophages and DC, chemotaxis of neutrophils, modulation of TLR activity, necrosis –> DAMP release, change of microbiome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the formation of ab against citrullinated proteins 3) in RA

A

Local inflammation reaction -> increase of PAD expression -> increased citrullination of proteins (generation of neoepitopes)
Presentation of citrullinated neoantigens by activated DC -> activation of citrulline-specific T cells in SLT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Name other sites of autoimmune reactions in RA

A

Oral mucosa (periodontits, citrullinated proteins and PAD increase, detection of ACPA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Name features of periarticular and clinical phase

A

Periarticular: increased ACPA, RF+, no joint involvement

Clinical: systemic loss of tolerance, joint involvement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ACPA are probably ___ because they stimulate…

A

Pathogenic

complement,macrophages, osteoclasts, neutrophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Explain the putative mechanism that lead from mucosal immunity to joint inflammation

A
Increase of citrullinated proteins in healthy joints --> PAD expression by osteoclasts
various target structures in the joint (synovial membrane, citrullinated collagen type 2 in cartilage)
Epitope spreading (detection of multiple epitopes in one molecule)
Cross reactivity of ACPA (collagen type 2 and vimentin)

Adaptive immune system: T cell indepent activation of B cells by TLR crosslinking and stress (inflammation, neutrophils)

T cell dependent B cell activation: exact mechanism unknown (Acpa, RF incerased, citrulline-reactive T cells in HC with RA background)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What does the PAD, what subtypes exist und which ones are associated to RA?

A
posttranslational conversion of arginine to citrulline (peptidyl-arginine deiminase)
PAD1+3: epidermis
PAD2: spleen, muscle, macrophages --> RA
PAD4: macrophages, neutrophils --> RA
PAD&: germ cells

usually intracellular and inactive, activation by incerased Ca2+ levels –> loss of membrane integrity –> extracellular PAD release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What happens during the citrullination of the synovium in RA?

A

Inflitration of leuko- and monocytes –>differentiation into macrophages –> PAD2 increase
massive cells death/defective clearance
enhanced intraellular CA2+ influx, activation of PAD –> citrullination of vimentin
extracellular PAD release -> activation -> citrullination of extracellular proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What kind of cytokines play a role in RA?

A

Th1 secrete IL2, IFNg and stimulate macrophages, B cells, fibroblasts and osteoclasts

  • Macrophages secrete TNFa, IL1, IL6
  • AUto-ab form immune complexes –> complement and Fc receptors –> TNFa
  • Fibroblasts secrete further cytokines + MMP –> destruction of cartilage and bone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Genetics of RA: Whats the stronges association, what aa is important, how is the theory called?

A

HLA-DRB1 (conserved region at position 70-74 = shared epitope)
conseved aa at 71 (Lys71) determines aa that fits into binding pocket P4 of HLA antogen binding groove
P4 (HLA-DRB1*04:01, Lsy71 (+), binds citrulline instead of arginine

–> favoured presentation of citrullinated selfantigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which HLA is resistamt for RA?

A

HLA-DRB1*04:02 (asp70, glu71) P4 is neg. charged. Binds both citrulline and arginine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

In which gene are SNPs for RA and how to they influence it?

A

PAD4

no effect on function but increased mRNA stability -> PAD expression increased

17
Q

Name some clinical symptoms in RA

A

Typical symmetrical joint involvement, hyperplasia of synovial membrane, de novo synthesis of vessels, pannus formation, erosion of cartilage and bone

18
Q

What kind of systemic involvement can occur in RA?

A

Lung (pulmonary fibrosis). pericarditis, inflammation of various layers of the eye, glomerulonephritis, anemia, CNS involvement, sicca syndrome, vasculitis, rheumatic nodules

19
Q

Name comorbidities of RA

A

fatigue, depression, asthma, ostoporosis, cardiovascular events

20
Q

How is RA diagnosed?

A

more than 2 joints painful for < 6 weeks, polyarticular, symmetric
stiffness <60min
examination of swollen and painful joints using the DAS28 score

Laboratory parameters: ESR + CRP, ferritin, RF, ACPA

21
Q

How many points do you need in the ACR/EULAR classification for RA?

A

> 6

22
Q

What kind of therapy options do you have in RA?

A
  • Glucocorticoids (rapid action, no effect on disease progression, side effects!)
  • NSAIDS (anti-infla., pain killer, mo effect on disease progression, only + DMARDS)
  • DMARDS (influence disease progression)

Conventional, synthetic: MTX, Leflunomide, SUlfasalazine, Hydroxychloroqiune
-no pain killer, onset takes week to month

bo/bsDMARDS (biologicals, mainly mAbs), supress inflammatory pathways: TNFa, IL1R, IL6R, CD20mab, CTLA-4

targeted, synthetic DMARDS: JAK inhibitors, Tofacitinib (JAK 1,2,3 inhibitor)